Gain-of-function mutations in PCSK9 are associated with familial hypercholesterolemia, leading to very elevated cholesterol levels and accelerated ASCVD.

“and then in 2006 the group of helen hobbs at ut southwestern had shown that there are common variants in pcsk9 that are associated with lower levels of of pcsk9 lower levels of ldl and protection against cardiovascular diseases”